CSIMarket Company Name, Ticker, Suppliers, else..
 
Healthcare Sector

Major Pharmaceutical Preparations Industry  



Data by Company within Major Pharmaceutical Preparations Industry
  Marketcap Revenues (TTM) Net Income (TTM) Employees
Company (Millions) (Millions) (Millions) Number
Eli Lilly And Company $ 474,035 $ 29,516 $ 6,498 35,000
Johnson and Johnson $ 413,539 $ 96,041 $ 19,157 141,700
Abbvie Inc $ 261,223 $ 56,023 $ 8,692 50,000
Merck and Co Inc $ 258,093 $ 52,525 $ 14,189 68,000
Beigene Ltd $ 242,800 $ 1,811 $ -1,728 4,344
Novartis Ag $ 223,083 $ 51,828 $ 6,955 110,000
Pfizer Inc $ 195,254 $ 92,367 $ 25,009 79,000
Glaxosmithkline Plc $ 182,742 $ 34,114 $ 5,096 99,437
Abbott Laboratories $ 167,726 $ 40,226 $ 5,161 113,000
Bristol myers Squibb Company $ 119,836 $ 45,187 $ 7,977 32,200
Astrazeneca Plc $ 104,099 $ 44,351 $ 3,293 76,100
Regeneron Pharmaceuticals Inc $ 93,174 $ 12,671 $ 4,299 10,368
Vertex Pharmaceuticals Inc $ 90,575 $ 9,505 $ 3,365 3,900
Gw Pharmaceuticals Plc $ 82,891 $ 343 $ -21 888
Zoetis Inc $ 79,957 $ 8,222 $ 2,209 12,100
Sanofi $ 67,345 $ 50,836 $ 9,502 100,000
Alexion Pharmaceuticals Inc $ 40,625 $ 6,262 $ 535 3,837
Theralink Technologies Inc $ 32,990 $ 1 $ -48 -
Horizon Therapeutics Public Limited Company $ 27,120 $ 3,643 $ 438 1,450
Takeda Pharmaceutical Company Limited $ 23,987 $ 27,902 $ 2,196 -
Zai Lab Limited $ 22,992 $ 252 $ -393 656
Akari Therapeutics Plc $ 22,553 - $ -18 15
Alnylam Pharmaceuticals Inc $ 22,309 $ 1,237 $ -1,064 1,450
Legend Biotech Corporation $ 18,296 $ 90 $ -386 345
Biomarin Pharmaceutical Inc $ 16,980 $ 2,235 $ 100 3,456
Royalty Pharma Plc $ 16,243 $ 2,361 $ 471 70
Hutchmed china Limited $ 14,164 $ 426 $ -360 406
Viatris Inc $ 12,060 $ 15,602 $ 1,854 37,000
Teva Pharmaceutical Industries Limited $ 11,211 $ 15,017 $ -2,331 40,000
Dr Reddy s Laboratories Limited $ 11,040 $ 2,992 $ 548 22,000
United Therapeutics Corporation $ 10,996 $ 2,111 $ 872 1,044
Sarepta Therapeutics Inc $ 10,524 $ 1,003 $ -908 1,400
Verona Pharma Plc $ 9,815 - $ -52 64
Prometheus Biosciences Inc $ 9,488 $ 4 $ -151 -
Jazz Pharmaceuticals Plc $ 9,393 $ 4,039 $ -187 1,720
Pharming Group N v $ 8,323 $ 199 $ 16 180
Roivant Sciences Ltd $ 7,984 $ 79 $ -1,090 -
Catalent Inc $ 7,774 $ 4,937 $ 378 19,000
Reata Pharmaceuticals Inc $ 7,154 $ 3 $ -88 339
Ionis Pharmaceuticals Inc $ 6,199 $ 585 $ -312 773
Arena Pharmaceuticals Inc $ 6,139 $ 3 $ -616 161
Karuna Therapeutics Inc $ 6,100 $ 11 $ -354 10
Puretech Health Plc $ 6,028 $ 16 $ -37 -
Iveric Bio Inc $ 5,477 - $ -223 91
Elanco Animal Health Inc $ 5,399 $ 4,323 $ -98 6,550
Ascendis Pharma A $ 5,110 $ 57 $ -653 -
Intra cellular Therapies Inc $ 5,036 $ 366 $ -184 200
Alkermes Plc $ 4,815 $ 1,462 $ 103 2,500
Global Blood Therapeutics Inc. $ 4,493 $ 235 $ -322 540
Apellis Pharmaceuticals Inc $ 4,444 $ 185 $ -657 -
Perrigo Company Plc $ 4,202 $ 4,203 $ 149 -
Organon and Co $ 4,169 $ 6,168 $ 754 9,300
Immunogen inc $ 4,155 $ 190 $ -182 200
Bridgebio Pharma Inc $ 4,079 $ 6 $ -584 -
Structure Therapeutics Inc $ 4,056 - $ 0 -
Turning Point Therapeutics Inc. $ 3,778 $ 1 $ -342 111
Chemocentryx Inc. $ 3,703 $ 75 $ -133 -
Insmed Inc $ 3,490 $ 268 $ -696 400
Cerevel Therapeutics Holdings Inc $ 3,281 - $ -397 44
Amicus Therapeutics inc $ 3,230 $ 350 $ -185 1,246
Bausch Health Companies Inc $ 2,988 $ 8,350 $ -189 21,000
Dicerna Pharmaceuticals Inc $ 2,971 $ 193 $ -124 190
Blueprint Medicines Corporation $ 2,957 $ 202 $ -554 582
Axsome Therapeutics Inc $ 2,919 $ 182 $ -184 48
Chinook Therapeutics Inc $ 2,892 $ 6 $ -246 -
Corcept Therapeutics Inc $ 2,881 $ 428 $ 94 289
Prestige Consumer Healthcare Inc $ 2,873 $ 1,129 $ -86 525
Arrowhead Pharmaceuticals Inc $ 2,809 $ 256 $ -184 211
Provention Bio Inc $ 2,683 $ 13 $ -114 -
Cytokinetics Incorporated $ 2,676 $ 10 $ -540 202
Madrigal Pharmaceuticals Inc $ 2,625 - $ -330 36
Myovant Sciences Ltd $ 2,613 $ 379 $ -184 450
Nuvalent Inc $ 2,605 $ 4 $ -100 -
Moonlake Immunotherapeutics $ 2,517 - $ -69 -
Prothena Corporation Public Limited Company $ 2,474 $ 58 $ -141 -
Ultragenyx Pharmaceutical Inc $ 2,467 $ 403 $ -721 1,000
Mirati Therapeutics Inc $ 2,445 $ 27 $ -738 -
Amphastar Pharmaceuticals Inc $ 2,429 $ 541 $ 102 2,146
Acadia Pharmaceuticals Inc $ 2,392 $ 551 $ -111 780
Akero Therapeutics Inc $ 2,374 - $ -116 58
Dynavax Technologies Corporation $ 2,279 $ 459 $ 110 235
Galapagos Nv $ 2,259 $ 543 $ -116 1,429
Dice Therapeutics Inc $ 2,250 - $ -104 10
Xenon Pharmaceuticals Inc $ 2,177 $ 13 $ -164 -
Schrodinger Inc $ 2,066 $ 194 $ 66 -
Can fite Biopharma Ltd $ 2,031 $ 1 $ -10 -
Harmony Biosciences Holdings inc $ 1,971 $ 499 $ 200 197
Trillium Therapeutics Inc $ 1,934 $ 0 $ 42 41
Ventyx Biosciences Inc $ 1,826 - $ -158 -
Ironwood Pharmaceuticals inc $ 1,751 $ 394 $ 526 970
Evotec Se $ 1,670 $ 842 $ -197 3,072
Kadmon holdings inc $ 1,648 $ 16 $ -121 -
Biohaven Ltd $ 1,643 $ 860 $ -731 274
Constellation Pharmaceuticals Inc $ 1,626 - $ -141 114
Ptc Therapeutics inc $ 1,566 $ 770 $ -571 700
Rocket Pharmaceuticals Inc $ 1,565 - $ -249 143
Pacira Biosciences inc $ 1,554 $ 669 $ -5 1,243
Cymabay Therapeutics Inc $ 1,500 - $ -81 27
Zogenix Inc $ 1,495 $ 82 $ -227 21,230
Supernus Pharmaceuticals inc $ 1,478 $ 634 $ 43 960
Crinetics Pharmaceuticals Inc $ 1,473 $ 5 $ -184 -
Ideaya Biosciences Inc $ 1,453 $ 45 $ -74 -
Taro Pharmaceutical Industries Ltd $ 1,403 $ 573 $ 25 5,860
Northwest Biotherapeutics inc $ 1,377 $ 2 $ -87 16
Biolinerx Ltd $ 1,362 - $ -27 53
Agios Pharmaceuticals Inc $ 1,347 $ 20 $ -210 -
Catalyst Pharmaceuticals Inc $ 1,339 $ 303 $ 116 94
Radius Health inc. $ 1,326 $ 223 $ -69 250
Abcellera Biologics Inc $ 1,289 $ 145 $ -74 220
Maravai Lifesciences Holdings Inc $ 1,278 $ 544 $ 174 1,400
Amylyx Pharmaceuticals Inc $ 1,271 $ 192 $ -73 80
Arcus Biosciences Inc $ 1,266 $ 121 $ -287 21,164
Rhythm Pharmaceuticals inc $ 1,257 $ 51 $ -200 -
Summit Therapeutics Inc $ 1,235 $ 2 $ -598 70
Imago Biosciences Inc $ 1,216 - $ -26 22
Kiniksa Pharmaceuticals Ltd $ 1,211 $ 281 $ 231 186
Zentalis Pharmaceuticals Inc $ 1,207 - $ -285 105
Cti Biopharma Corp $ 1,196 $ 76 $ -69 -
Cincor Pharma Inc $ 1,186 - $ 0 -
Sage Therapeutics Inc $ 1,181 $ 10 $ -592 -
Xencor Inc $ 1,165 $ 113 $ -128 201
Innoviva Inc $ 1,165 $ 311 $ 217 540
Tg Therapeutics inc $ 1,155 $ 24 $ -176 132
Sierra Oncology Inc $ 1,153 - $ -103 -
Opko Health Inc $ 1,150 $ 868 $ -209 4,500
Aeglea Biotherapeutics Inc $ 1,118 $ 1 $ -273 -
Marizyme Inc $ 1,117 $ 0 $ -35 -
Mirum Pharmaceuticals Inc $ 1,117 $ 116 $ -176 -
Geron Corp $ 1,089 $ 0 $ -171 25
Merus N v $ 1,087 $ 41 $ -178 -
Viking Therapeutics Inc $ 1,076 - $ -74 11
Deciphera Pharmaceuticals Inc $ 1,073 $ 144 $ -187 288
Mannkind Corporation $ 1,070 $ 158 $ -47 191
89bio Inc $ 1,069 - $ -119 20
Eqrx Inc $ 1,065 - $ -262 -
Aurinia Pharmaceuticals Inc $ 1,062 $ 160 $ -73 71
Ligand Pharmaceuticals Incorporated $ 1,049 $ 163 $ 27 149
Ani Pharmaceuticals Inc $ 1,015 $ 401 $ -5 685
Arvinas Inc $ 1,006 $ 163 $ -423 133
Tango Therapeutics Inc $ 994 $ 34 $ -107 -
Disc Medicine Inc $ 981 - $ -63 -
Collegium Pharmaceutical inc $ 975 $ 494 $ -11 253
Pliant Therapeutics Inc $ 950 $ 5 $ -144 -
Syndax Pharmaceuticals Inc $ 940 $ 140 $ -160 38
Revance Therapeutics Inc $ 937 $ 186 $ -2 348
Mei Pharma Inc $ 930 $ 49 $ -32 -
Protagonist Therapeutics inc $ 928 $ 45 $ -138 -
Keros Therapeutics Inc $ 912 - $ -127 60
Calliditas Therapeutics Ab $ 904 $ 86 $ -44 60
Day One Biopharmaceuticals Inc $ 900 - $ -28 -
Morphic Holding inc $ 890 $ 69 $ -130 -
Gracell Biotechnologies Inc $ 876 - $ -88 365
Albireo Pharma inc $ 868 $ 57 $ -131 -
Ardelyx inc $ 841 $ 63 $ -66 -
Intercept Pharmaceuticals inc $ 776 $ 277 $ 209 452
Avadel Pharmaceuticals Plc $ 767 $ 44 $ -143 -
Zealand Pharma A $ 754 $ 293 $ -1,018 390
Sinovac Biotech Ltd $ 739 $ 1,493 $ 88 1,000
Verve Therapeutics Inc $ 730 $ 5 $ -192 -
Cogent Biosciences Inc $ 714 $ 8 $ -157 -
Point Biopharma Global Inc $ 707 - $ 97 50
Cassava Sciences Inc $ 702 - $ -90 -
Mereo Biopharma Group Plc $ 695 $ 36 $ 13 46
Arcturus Therapeutics Holdings Inc $ 681 $ 264 $ 80 122
Amneal Pharmaceuticals Inc $ 646 $ 2,094 $ -273 6,500
Cryoport inc $ 640 $ 241 $ -47 31
Travere Therapeutics Inc $ 640 $ 226 $ -307 500
Wave Life Sciences Ltd $ 635 $ 37 $ -131 -
Pharvaris N v $ 622 - $ -48 -
Genelux Corporation $ 620 - $ 0 -
Aslan Pharmaceuticals Limited $ 613 $ 3 $ -32 -
Rapt Therapeutics Inc $ 613 $ 3 $ -99 41
Bicycle Therapeutics Plc $ 602 $ 23 $ -140 -
Kura Oncology Inc $ 600 - $ -140 66
Xtl Biopharmaceuticals Ltd $ 585 - $ -1 -
Avid Bioservices Inc $ 577 $ 150 $ -3 326
Biodelivery Sciences International Inc $ 575 $ 167 $ 85 120
Vera Therapeutics Inc $ 573 - $ -107 -
Enliven Therapeutics Inc $ 560 - $ -4 -
Tyra Biosciences Inc $ 557 - $ -51 -
Thorne Healthtech Inc $ 549 $ 256 $ 20 -
Alpine Immune Sciences Inc $ 546 $ 29 $ -59 36
Savara Inc $ 544 - $ -43 -
Centessa Pharmaceuticals Plc $ 535 - $ -173 350
Aveo Pharmaceuticals Inc $ 519 $ 95 $ -29 -
Phibro Animal Health Corporation $ 513 $ 977 $ 33 1,400
Repare Therapeutics Inc $ 496 $ 167 $ -3 124
Evolus Inc $ 493 $ 169 $ -66 130
Entrada Therapeutics Inc $ 492 - $ -67 89
Phathom Pharmaceuticals Inc $ 492 - $ -185 55
Theravance Biopharma inc $ 492 $ 51 $ 869 -
Akouos inc $ 490 - $ -93 148
Dyne Therapeutics Inc $ 477 $ 3,055 $ -189 -
Olema Pharmaceuticals inc $ 475 - $ -97 30
Anaptysbio inc $ 469 $ 13 $ -144 -
Flexion Therapeutics Inc $ 458 $ 100 $ -101 215
Aclaris Therapeutics Inc $ 458 $ 31 $ -105 -
Gh Research Plc $ 450 - $ -9 -
Biomea Fusion Inc $ 449 - $ -102 33
23andme Holding Co $ 441 $ 296 $ -327 700
Avidity Biosciences Inc $ 424 $ 10 $ -193 -
Harrow Health Inc $ 423 $ 103 $ -16 257
Kindred Biosciences Inc $ 419 $ 8 $ -42 -
Zymeworks Inc $ 416 $ 448 $ 186 600
Concert Pharmaceuticals Inc $ 416 $ 33 $ -186 107
Liquidia Corporation $ 404 $ 18 $ -51 -
Janux Therapeutics Inc $ 397 $ 8 $ -68 -
Marinus Pharmaceuticals Inc $ 396 $ 26 $ -28 -
Organogenesis Holdings Inc $ 395 $ 456 $ 9 896
Nurix Therapeutics Inc $ 392 $ 61 $ -157 100
Adamas Pharmaceuticals Inc $ 375 $ 88 $ -63 120
Siga Technologies Inc $ 371 $ 98 $ 28 60
Edgewise Therapeutics inc $ 366 - $ -10 14
Ars Pharmaceuticals Inc $ 364 - $ -23 -
Procaps Group S a $ 364 $ 410 $ 43 -
Lyell Immunopharma Inc $ 358 $ 48 $ -210 -
Aldeyra Therapeutics Inc $ 356 - $ -52 152
Terns Pharmaceuticals Inc $ 350 - $ -72 51
Molecular Templates inc $ 350 $ 20 $ 93 45
Amarin Corp Plcuk $ 345 $ 277 $ -38 1,040
Nature s Sunshine Products inc $ 334 $ 432 $ 6 2,100
Aerovate Therapeutics inc $ 329 - $ -65 10
Igm Biosciences Inc $ 326 - $ -234 170
Urogen Pharma Ltd $ 321 $ 72 $ -109 -
Precigen Inc $ 320 - $ 22 -
Nanobiotix S a $ 320 $ 5 $ -64 -
Arbutus Biopharma Corp $ 319 $ 24 $ -8 93
Compass Pathways Plc $ 313 - $ -102 76
Kalvista Pharmaceuticals Inc $ 309 $ 13 $ -95 -
An2 Therapeutics Inc $ 302 $ 1 $ -54 -
Uniqure N v $ 294 $ 112 $ -187 -
Arcutis Biotherapeutics Inc $ 290 $ 12 $ -331 68
Erasca Inc $ 290 - $ -226 100
Nuvation Bio Inc $ 289 - $ -90 -
Tonix Pharmaceuticals Holding Corp $ 279 - $ -98 -
Seres Therapeutics Inc $ 279 $ 130 $ -153 -
Macrogenics Inc $ 279 $ 152 $ 7 423
Pmv Pharmaceuticals Inc $ 272 - $ -74 -
Redhill Biopharma Ltd $ 269 $ 62 $ 72 158
Oric Pharmaceuticals Inc $ 269 - $ -93 51
Innovation Pharmaceuticals Inc $ 266 - $ -3 -
Liminal Biosciences Inc $ 256 $ 0 $ 9 790
Fulcrum Therapeutics Inc $ 256 $ 3 $ -98 -
Scpharmaceuticals Inc $ 254 - $ -45 2,191
Ovid Therapeutics Inc $ 251 $ 0 $ -49 51
Atea Pharmaceuticals Inc $ 250 $ 351 $ -106 12
I mab $ 247 - $ -364 -
Epizyme Inc. $ 245 $ 53 $ -208 -
Kamada Ltd $ 240 $ 104 $ -2 495
Xeris Biopharma Holdings Inc $ 240 $ 121 $ -33 100
Vanda Pharmaceuticals Inc $ 240 $ 238 $ 15 500
Chiasma Inc $ 236 - $ -90 87
Y mabs Therapeutics inc $ 234 $ 40 $ -117 -
Ocular Therapeutix Inc $ 230 $ 55 $ -91 -
Mineralys Therapeutics Inc $ 226 - $ 0 -
Neoleukin Therapeutics Inc $ 222 - $ -61 -
Enanta Pharmaceuticals Inc $ 221 $ 81 $ -132 112
Morphosys Ag $ 214 $ 201 $ -576 434
Ac Immune Sa $ 213 - $ -73 109
Reneo Pharmaceuticals Inc $ 212 - $ -61 -
Generation Bio Co $ 211 - $ -127 174
Lexicon Pharmaceuticals Inc $ 209 $ 0 $ -131 219
Akebia Therapeutics Inc $ 208 $ 292 $ -94 384
Spectrum Pharmaceuticals Inc $ 208 $ 109 $ -65 1
Immuneering Corporation $ 203 $ 0 $ -52 11
2seventy Bio Inc $ 202 $ 147 $ -180 -
Regulus Therapeutics Inc $ 201 $ 0 $ -27 50
Trevi Therapeutics Inc $ 200 - $ -27 30
Acelyrin Inc $ 200 - $ 0 -
Synlogic Inc $ 200 $ 1 $ -65 -
Eagle Pharmaceuticals inc $ 200 $ 258 $ 12 261
Applied Therapeutics Inc $ 199 - $ -73 -
Astria Therapeutics inc $ 198 - $ -49 10
Acrivon Therapeutics Inc $ 198 - $ -27 -
Chemomab Therapeutics Ltd $ 197 - $ 31 9
Alx Oncology Holdings Inc $ 197 - $ -130 17
Atai Life Sciences N v $ 193 $ 0 $ -150 -
Allakos Inc $ 191 - $ -151 149
Rockwell Medical inc $ 190 $ 62 $ -33 -
Foghorn Therapeutics Inc $ 186 $ 22 $ -115 -
Verrica Pharmaceuticals Inc $ 184 $ 9 $ -23 -
Rigel Pharmaceuticals Inc $ 179 $ 127 $ -38 135
Pasithea Therapeutics Corp $ 179 $ 0 $ -17 -
China Health Industries Holdings Inc $ 177 $ 0 $ 0 -
Inozyme Pharma Inc $ 176 - $ -68 56
Merrimack Pharmaceuticals Inc $ 175 - $ -3 117
Omeros Corporation $ 174 - $ 40 450
Nuvectis Pharma inc $ 173 - $ 0 -
Carisma Therapeutics Inc $ 172 - $ -23 -
Assertio Holdings inc $ 172 $ 168 $ 98 300
Inventiva S a $ 167 - $ -56 -
Larimar Therapeutics Inc $ 166 - $ -33 110
Stoke Therapeutics Inc $ 163 $ 9 $ -105 -
Annexon Inc $ 162 - $ -143 52
Zomedica Corp $ 162 $ 21 $ -19 -
Xoma Corporation $ 161 $ 4 $ -31 -
Vaxxinity Inc $ 161 - $ -72 -
Cormedix Inc $ 161 $ 0 $ -37 17
Emergent Biosolutions Inc $ 160 $ 1,074 $ -608 2,100
Zevra Therapeutics Inc $ 160 $ 17 $ -32 -
Selecta Biosciences Inc $ 160 $ 49 $ -35 60
Lianbio $ 156 - $ 0 600
F star Therapeutics Inc $ 156 - $ -44 56
Cytodyn Inc $ 148 - $ -80 25
Actinium Pharmaceuticals Inc $ 147 $ 1 $ -46 23
Mersana Therapeutics inc $ 146 $ 39 $ -215 -
Cyclerion Therapeutics Inc $ 146 $ 2 $ -38 -
Pds Biotechnology Corp $ 145 - $ -48 20
Clever Leaves Holdings Inc $ 140 $ 17 $ -57 -
Karyopharm Therapeutics Inc $ 139 $ 146 $ -142 315
Verastem Inc $ 139 $ 4 $ -75 73
Strongbridge Biopharma plc $ 136 $ 35 $ -40 156
Ys Biopharma Co Ltd $ 135 $ 100 $ -21 -
Optinose Inc $ 133 $ 72 $ -46 -
Prelude Therapeutics Inc $ 131 - $ 27 11
Pardes Biosciences Inc $ 130 - $ -76 -
Essa Pharma inc $ 130 $ 1 $ -27 18
Milestone Pharmaceuticals Inc $ 129 - $ -59 47
Altimmune inc $ 129 - $ -81 50
Design Therapeutics Inc $ 128 - $ -74 -
Rallybio Corporation $ 127 - $ -71 -
Paratek Pharmaceuticals Inc $ 127 $ 167 $ -66 200
Vaccitech Plc $ 123 $ 13 $ -55 -
Decibel Therapeutics Inc $ 123 - $ -63 -
Biophytis Sa $ 122 - $ -35 -
Oncolytics Biotech Inc $ 121 - $ -19 -
Puma Biotechnology Inc $ 121 $ 230 $ -2 460
Heron Therapeutics Inc $ 118 $ 118 $ -137 336
Xbiotech Inc $ 117 $ 8 $ -28 -
Praxis Precision Medicines Inc $ 116 - $ -157 -
Inflarx N v $ 116 - $ -33 100
Aadi Bioscience Inc $ 116 $ 22 $ -62 -
Greenwich Lifesciences Inc $ 115 - $ -7 -
Galectin Therapeutics Inc $ 114 - $ -40 11
Longboard Pharmaceuticals Inc $ 113 - $ -49 -
Theseus Pharmaceuticals Inc $ 112 - $ -58 -
Pepgen Inc $ 110 - $ -69 -
Scynexis Inc $ 109 $ 136 $ 44 100
Nektar Therapeutics $ 108 $ 88 $ -307 725
Reviva Pharmaceuticals Holdings Inc $ 106 - $ -31 12
Opiant Pharmaceuticals Inc $ 106 $ 22 $ -33 -
Esperion Therapeutics Inc $ 106 $ 88 $ -222 -
Entasis Therapeutics Holdings Inc $ 105 - $ -52 25
Eton Pharmaceuticals Inc $ 103 $ 29 $ 0 -
Oramed Pharmaceuticals Inc $ 103 $ 3 $ 23 21
Citius Pharmaceuticals Inc $ 103 - $ -31 1
Cyteir Therapeutics Inc $ 102 $ 1,545 $ -41 46
Viveon Health Acquisition Corp $ 101 - $ 0 -
Immunome Inc $ 100 - $ -39 -
Medicinova Inc $ 100 - $ -12 8
Ngm Biopharmaceuticals Inc $ 96 $ 30 $ -170 -
Elite Pharmaceuticals Inc $ 95 $ 33 $ 3 67
Anixa Biosciences Inc $ 95 - $ -11 15
Cue Biopharma Inc $ 94 $ 2 $ -52 50
Biovie Inc $ 93 - $ 44 6
Briacell Therapeutics Corp $ 92 - $ 0 -
Relmada Therapeutics Inc $ 92 - $ -129 11
Atossa Therapeutics Inc $ 90 - $ -32 9
Syros Pharmaceuticals Inc $ 90 $ 9 $ -95 -
Cara Therapeutics inc $ 89 $ 27 $ -112 -
Spruce Biosciences Inc $ 88 - $ -48 -
Ocean Biomedical Inc $ 87 - $ -69 -
Chimerix inc $ 86 $ 34 $ 180 181
Lifevantage Corp $ 85 $ 213 $ 3 247
Flora Growth Corp $ 84 - $ 0 -
Benitec Biopharma Inc $ 84 $ 0 $ -20 -
Sonnet Biotherapeutics Holdings Inc $ 84 $ 0 $ -30 -
Kezar Life Sciences Inc $ 83 - $ -83 -
Cytomx Therapeutics Inc $ 83 $ 66 $ -56 138
G1 Therapeutics Inc $ 83 $ 89 $ -78 -
Annovis Bio inc $ 81 - $ -30 812
Anebulo Pharmaceuticals Inc $ 80 - $ -12 -
Aquestive Therapeutics Inc $ 80 $ 47 $ -23 -
Fibrogen Inc $ 79 $ 131 $ -322 832
Pyxis Oncology Inc $ 79 - $ -99 11
Ocuphire Pharma Inc $ 76 - $ 19 -
Prophase Labs Inc $ 75 $ 78 $ -4 24
Capricor Therapeutics inc $ 75 $ 9 $ -29 11
Aptorum Group Limited $ 75 - $ -27 31
Glycomimetics Inc $ 74 $ 1 $ -50 -
Aditxt Inc $ 74 $ 1 $ -27 -
Gossamer Bio Inc $ 73 - $ -207 62
Werewolf Therapeutics Inc $ 73 $ 25 $ -41 -
Kronos Bio Inc $ 72 - $ -120 57
Bioxcel Therapeutics Inc $ 71 $ 1 $ -203 51
Affimed N v $ 70 $ 45 $ -64 -
Eliem Therapeutics Inc $ 70 - $ -45 -
Intercure Ltd $ 70 $ 389 $ 44 11
Diamedica Therapeutics Inc $ 68 - $ -17 -
Tiziana Life Sciences Ltd $ 68 - $ -15 -
Corvus Pharmaceuticals Inc $ 67 - $ -39 -
Hcw Biologics Inc $ 66 $ 4 $ -19 -
Homology Medicines Inc $ 66 $ 3 $ -132 -
Kinnate Biopharma Inc $ 66 - $ -127 -
Veru Inc $ 64 $ 15 $ -110 1,300
Nkarta Inc $ 64 - $ -125 -
Shattuck Labs Inc $ 64 $ 1 $ -92 -
Zynerba Pharmaceuticals Inc $ 64 - $ -38 -
Rezolute Inc $ 64 - $ -52 -
Immunic Inc $ 63 - $ -127 -
Proqr Therapeutics N v $ 63 - $ 0 100
Spero Therapeutics Inc $ 63 $ 54 $ -10 -
Vaccinex Inc $ 62 $ 1 $ 0 -
Durect Corp $ 62 $ 19 $ -36 -
Immix Biopharma Inc $ 60 - $ -8 -
Eyenovia inc $ 59 - $ -25 7
Xilio Therapeutics inc $ 58 - $ -84 51
Adicet Bio Inc $ 56 $ 39 $ -115 50
Sigilon Therapeutics Inc $ 56 $ 18 $ -30 -
Ampio Pharmaceuticals inc $ 55 $ 0 $ -14 -
Connect Biopharma Holdings Limited $ 54 - $ -114 -
Clearside Biomedical Inc $ 54 $ 2 $ -36 -
Tyme Technologies Inc. $ 54 - $ -24 -
Rani Therapeutics Holdings Inc $ 52 - $ -69 100
Journey Medical Corporation $ 50 $ 61 $ -39 -
Hookipa Pharma inc $ 49 $ 16 $ -68 -
Murphy Canyon Acquisition Corp $ 48 - $ 1 -
Longeveron Inc $ 48 $ 0 $ -4 -
Kyto Technology And Life Science Inc $ 46 $ 0 $ 1 -
Kineta Inc $ 45 $ 9 $ -73 -
Sellas Life Sciences Group Inc $ 45 - $ -36 -
Assembly Biosciences Inc $ 44 $ 79 $ -81 -
Immunoprecise Antibodies Ltd $ 44 $ 16 $ -20 -
Intec Pharma Ltd $ 43 - $ -14 -
Odonate Therapeutics Inc $ 42 - $ -102 10
Magenta Therapeutics Inc $ 42 - $ -69 -
Clene Inc $ 42 $ 1 $ -49 -
Rapid Therapeutic Science Laboratories Inc $ 42 - $ 0 -
Dar Bioscience Inc $ 41 - $ -40 10
Gain Therapeutics inc $ 41 $ 0 $ -22 -
Vtv Therapeutics Inc $ 40 $ 5 $ -25 -
Bolt Biotherapeutics Inc $ 40 $ 7 $ -77 -
Societal Cdmo Inc $ 40 $ 89 $ -20 -
Viracta Therapeutics Inc $ 40 - $ -74 -
Celularity Inc $ 40 $ 15 $ -83 201
Io Biotech Inc $ 39 - $ -74 -
Marker Therapeutics inc $ 39 $ 13 $ -13 -
Coya Therapeutics Inc $ 39 - $ 0 -
Mainz Biomed N v $ 39 $ 1 $ -26 -
Eledon Pharmaceuticals Inc $ 37 - $ -89 -
Minerva Neurosciences Inc $ 37 - $ -27 -
Sol gel Technologies Ltd $ 37 $ 31 $ 3 -
Satsuma Pharmaceuticals Inc $ 36 - $ -65 -
Nextcure Inc $ 36 - $ -70 -
Lantern Pharma Inc $ 36 - $ -14 -
Oculis Holding Ag $ 35 - $ 0 -
Casi Pharmaceuticals inc $ 35 $ 43 $ -40 -
Betterlife Pharma Inc. $ 35 $ 339 $ -9 45
Fortress Biotech Inc $ 35 $ 63 $ -225 -
Provectus Biopharmaceuticals Inc $ 34 $ 1 $ -3 -
Maia Biotechnology Inc $ 33 - $ -5 -
Cellectar Biosciences Inc $ 32 - $ -37 -
Adc Therapeutics Sa $ 32 $ 34 $ -230 -
Beyondspring Inc $ 31 $ 1 $ -36 -
Rain Oncology Inc $ 31 - $ -83 -
Vistagen Therapeutics Inc $ 31 $ 1 $ -46 -
Alaunos Therapeutics Inc $ 31 - $ -37 -
Protagenic Therapeutics Inc new $ 31 - $ -4 -
Therapeuticsmd Inc $ 31 $ 23 $ 43 325
Orphazyme A $ 30 $ 36 $ -627 -
Unity Biotechnology Inc $ 30 - $ -48 -
Nucana Plc $ 30 - $ -41 -
Sio Gene Therapies Inc $ 29 - $ -29 -
Mallinckrodt Plc $ 29 $ 2,142 $ -847 3,600
Enlivex Therapeutics Ltd $ 28 - $ -31 -
Lumos Pharma Inc $ 28 $ 2 $ -32 -
Qilian International Holding Group Limited $ 28 $ 65 $ 1 -
Universe Pharmaceuticals Inc $ 28 $ 40 $ -9 -
Corbus Pharmaceuticals Holdings Inc $ 28 $ 2 $ -46 57
Matinas Biopharma Holdings Inc $ 27 $ 4 $ -20 230
Neubase Therapeutics inc $ 27 - $ -28 -
Effector Therapeutics Inc $ 27 - $ -37 -
Biora Therapeutics Inc $ 27 $ 0 $ -54 -
Agex Therapeutics Inc $ 27 - $ -5 -
Innovation1 Biotech Inc $ 26 $ 0 $ -46 -
Cumberland Pharmaceuticals Inc $ 26 $ 41 $ -2 96
Seelos Therapeutics inc $ 26 $ 1 $ -81 -
Checkpoint Therapeutics inc $ 25 $ 0 $ -59 19
Pieris Pharmaceuticals Inc $ 25 $ 33 $ -27 -
Equillium Inc $ 25 - $ -18 -
Metacrine Inc $ 25 - $ -38 -
Alimera Sciences Inc $ 24 $ 58 $ -24 -
Landos Biopharma Inc $ 24 - $ 2 -
Indaptus Therapeutics Inc $ 23 - $ -15 -
Cell Source Inc $ 23 - $ -6 -
Athenex Inc $ 23 $ 103 $ -104 1,115
Intelgenx Technologies Corp $ 23 $ 1 $ -11 -
Sensei Biotherapeutics Inc $ 23 - $ -45 -
Novabay Pharmaceuticals Inc $ 23 $ 9 $ -4 -
Context Therapeutics Inc $ 23 - $ -19 -
Vincerx Pharma Inc $ 22 - $ -56 -
Lftd Partners Inc $ 22 $ 48 $ 3 -
Priveterra Acquisition Corp $ 22 - $ -3 -
Kala Bio inc $ 21 $ 6 $ -9 -
Alzamend Neuro Inc $ 21 - $ -15 -
Nrx Pharmaceuticals Inc $ 21 - $ -39 -
Acasti Pharma Inc $ 21 - $ -42 -
Evelo Biosciences Inc $ 21 - $ -101 -
Bioxytran Inc $ 21 - $ -3 -
Bullfrog Ai Holdings Inc $ 20 - $ 0 -
Neptune Wellness Solutions Inc $ 20 $ 47 $ -89 208
Rasna Therapeutics Inc $ 20 $ 0 $ -4 -
Genprex Inc $ 19 - $ -30 -
Vascular Biogenics Ltd $ 19 $ 1 $ 66 -
Leap Therapeutics inc $ 19 $ 2 $ -82 -
Igc Pharma Inc $ 19 $ 1 $ -11 -
Cocrystal Pharma Inc $ 19 $ 2 $ -20 11
Acer Therapeutics Inc $ 19 - $ -39 -
Neurobo Pharmaceuticals Inc $ 19 - $ -11 -
Bright Minds Biosciences Inc $ 19 - $ -11 -
Palatin Technologies Inc $ 19 $ 5 $ -28 -
Catalyst Biosciences Inc $ 19 $ 7 $ 26 -
Oncternal Therapeutics Inc $ 18 $ 1 $ -43 -
Galecto Inc $ 18 - $ -52 -
Hepion Pharmaceuticals inc $ 18 - $ -43 -
Orgenesis Inc $ 18 $ 36 $ 11 111
Acurx Pharmaceuticals inc $ 17 - $ -13 -
Scisparc Ltd $ 17 $ 1 $ 3 -
Virios Therapeutics inc $ 16 - $ -4 -
Promis Neurosciences inc $ 16 - $ -5 -
Addex Therapeutics Ltd $ 16 $ 3 $ -15 -
Teligent Inc $ 16 $ 46 $ -92 -
Mustang Bio inc $ 16 - $ -75 330
Integrated Biopharma Inc $ 16 $ 50 $ 0 -
Nanoviricides inc $ 16 - $ -7 -
Onconova Therapeutics inc $ 15 $ 0 $ -19 10
Medicenna Therapeutics Corp. $ 15 - $ -17 -
Nls Pharmaceutics Ltd $ 15 - $ -16 -
Skye Bioscience Inc $ 15 - $ -21 -
Geovax Labs Inc $ 15 $ 0 $ -19 -
Aprea Therapeutics Inc $ 15 - $ -14 -
Inhibitor Therapeutics Inc $ 15 - $ 11 -
Lipocine Inc $ 15 $ 1 $ -12 -
Chembio Diagnostics Inc $ 15 $ 50 $ -23 -
Calcimedica Inc $ 14 - $ -43 -
Unicycive Therapeutics Inc $ 14 - $ -29 -
Frequency Therapeutics Inc $ 14 $ 35 $ -67 51
Ainos Inc $ 13 $ 3 $ -15 -
Edesa Biotech Inc $ 13 - $ -9 -
Nighthawk Biosciences inc $ 13 $ 8 $ -52 -
Aravive Inc $ 13 $ 9 $ -77 -
Nascent Biotech Inc $ 13 $ 0 $ -2 -
Forte Biosciences Inc $ 13 - $ -24 -
Moleculin Biotech Inc $ 13 - $ -29 -
Rvl Pharmaceuticals Plc $ 13 $ 36 $ -68 -
Vyne Therapeutics Inc $ 13 $ 0 $ -35 -
Immune Therapeutics Inc $ 12 - $ -4 -
Tff Pharmaceuticals Inc $ 12 $ 1 $ -27 -
Aeterna Zentaris Inc $ 12 $ 5 $ -8 -
Biofrontera Inc $ 12 $ 70 $ -23 -
Eterna Therapeutics Inc $ 12 - $ -22 50
Renovorx Inc $ 12 - $ -10 -
Gelesis Holdings Inc $ 12 $ 12 $ -53 -
Clovis Oncology inc $ 12 $ 133 $ -252 461
Oncotelic Therapeutics Inc $ 11 - $ -17 -
Dominari Holdings Inc $ 11 - $ -26 -
Immutep Ltd $ 11 $ 4 $ -30 -
Aytu Biopharma inc $ 11 $ 104 $ -32 20
Celyad Oncology Sa $ 11 $ 0 $ -30 -
Atreca inc $ 10 - $ -85 -
Gt Biopharma Inc $ 10 - $ -15 -
Bellicum Pharmaceuticals Inc $ 10 $ 1 $ -4 -
Iterum Therapeutics Plc $ 10 - $ -56 -
Apexigen Inc $ 10 - $ -40 -
Guardion Health Sciences Inc $ 10 $ 11 $ -11 -
Virpax Pharmaceuticals Inc $ 10 - $ -15 -
Imunon Inc $ 10 $ 1 $ -31 -
Inmed Pharmaceuticals Inc $ 9 $ 5 $ -13 -
Impel Pharmaceuticals Inc $ 9 $ 7 $ -92 -
Accustem Sciences Inc $ 9 - $ -3 -
Lipella Pharmaceuticals Inc $ 9 - $ 0 -
Diffusion Pharmaceuticals Inc $ 9 - $ -13 -
Timber Pharmaceuticals Inc $ 9 $ 1 $ -15 -
Athersys Inc $ 9 $ 5 $ -93 -
Cohbar Inc $ 9 - $ -13 -
Blue Water Biotech Inc $ 8 - $ -14 -
Cadrenal Therapeutics Inc $ 8 - $ 0 -
Shuttle Pharmaceuticals Holdings Inc $ 8 - $ -6 -
Cingulate Inc $ 8 - $ -19 -
Monopar Therapeutics Inc $ 8 - $ -10 -
Theriva Biologics inc $ 8 - $ -19 -
Obseva Sa $ 8 - $ 0 -
Lucy Scientific Discovery Inc $ 8 - $ 0 -
Obseva Sa $ 8 $ 20 $ -58 -
Galera Therapeutics Inc $ 7 - $ -71 -
Trevena inc $ 7 $ 0 $ -38 -
Applied Molecular Transport Inc $ 7 - $ -93 -
Jaguar Health inc $ 7 $ 11 $ -46 -
Pulmatrix Inc $ 7 $ 6 $ -19 -
Cv Sciences Inc $ 7 $ 15 $ 1 -
Processa Pharmaceuticals Inc $ 7 - $ -26 -
Aileron Therapeutics Inc $ 7 - $ -17 62
Tenax Therapeutics Inc $ 7 - $ 8 -
Kintara Therapeutics Inc $ 6 - $ -15 -
One World Products Inc $ 6 $ 0 $ -1 -
Tricida Inc $ 6 - $ -61 -
Exicure Inc $ 6 $ 29 $ 3 -
Lexaria Bioscience Corp $ 6 $ 0 $ -11 -
Oragenics Inc $ 6 $ 0 $ -12 14
Regen Biopharma Inc $ 6 $ 0 $ 7 3
Acelrx Pharmaceuticals Inc $ 6 $ 2 $ -32 -
Comera Life Sciences Holdings Inc $ 6 $ 1 $ -13 -
Xortx Therapeutics Inc $ 6 $ 0 $ -1 -
Vbi Vaccines Inc $ 6 $ 2 $ -119 -
Neximmune Inc $ 5 - $ -49 -
Avenue Therapeutics Inc $ 5 - $ -12 -
Qualigen Therapeutics Inc $ 5 $ 6 $ -20 -
Hoth Therapeutics Inc $ 5 - $ -10 -
Axim Biotechnologies Inc $ 5 $ 0 $ -9 -
Bellerophon Therapeutics inc $ 5 - $ -12 -
Enveric Biosciences Inc $ 5 - $ -22 -
Ayala Pharmaceuticals Inc $ 5 $ 4 $ -28 -
Evoke Pharma Inc $ 5 $ 4 $ -8 -
First Wave Biopharma Inc $ 5 - $ -64 -
Agile Therapeutics Inc $ 5 $ 16 $ -11 28
Aptinyx Inc $ 5 $ 2 $ -66 -
Nabriva Therapeutics Plc $ 5 $ 37 $ -54 123
Cyclacel Pharmaceuticals Inc $ 4 - $ -24 -
Cns Pharmaceuticals Inc $ 4 - $ -18 -
Peak Pharmaceuticals Inc $ 4 - $ 0 -
Tempest Therapeutics Inc $ 4 - $ -33 -
Paxmedica Inc $ 4 - $ -7 -
Immuron Limited $ 4 $ 1 $ -4 -
Soligenix inc $ 4 - $ -18 -
Artelo Biosciences Inc $ 4 - $ -9 -
Revelation Biosciences Inc $ 4 - $ 2 -
Lixte Biotechnology Holdings Inc $ 4 - $ -6 -
Petros Pharmaceuticals inc $ 4 - $ 0 -
Gri Bio Inc $ 4 - $ -12 -
Phasebio Pharmaceuticals Inc. $ 3 $ 1 $ -103 -
Azitra Inc $ 3 - $ 0 -
Abvc Biopharma Inc $ 3 $ 1 $ -12 -
180 Life Sciences Corp $ 3 - $ -52 -
Ensysce Biosciences Inc $ 3 $ 3 $ -20 -
Ibio inc $ 3 $ 2 $ -65 -
Bio path Holdings Inc $ 3 - $ -17 -
Adial Pharmaceuticals Inc $ 3 - $ -8 -
Emmaus Life Sciences Inc $ 3 $ 28 $ -5 -
Synaptogenix Inc $ 3 - $ 12 -
Aridis Pharmaceuticals Inc $ 3 $ 3 $ -29 -
Hst Global Inc $ 3 - $ 0 -
Dermata Therapeutics Inc $ 3 - $ -8 -
Plx Pharma Inc $ 2 $ 5 $ -25 -
Novan Inc $ 2 $ 25 $ -32 -
Zyversa Therapeutics Inc $ 2 - $ 0 -
Zosano Pharma Corporation $ 2 $ 1 $ -55 -
Aptevo Therapeutics Inc $ 2 $ 13 $ -17 -
Histogen Inc $ 2 $ 0 $ -12 -
Contrafect Corporation $ 2 - $ -36 27
Regenerx Biopharmaceuticals inc $ 2 $ 0 $ -2 -
Adamis Pharmaceuticals Corporation $ 2 $ 5 $ -25 -
Adhera Therapeutics Inc $ 2 $ 2,732 $ -3 11
Kiora Pharmaceuticals Inc $ 2 - $ -12 -
Endo International Plc $ 2 $ 2,160 $ -946 4,050
Salarius Pharmaceuticals inc $ 2 $ 5 $ -30 -
Globestar Therapeutics Corporation $ 2 - $ -2 -
60 Degrees Pharmaceuticals Inc $ 2 - $ 0 -
Procyon Corporation $ 2 $ 5 $ 0 -
Avalo Therapeutics Inc $ 2 $ 17 $ 17 -
Humanigen Inc $ 2 $ 2 $ -54 -
Scopus Biopharma Inc $ 2 - $ -9 -
Novaccess Global Inc $ 2 - $ -3 -
Nexien Biopharma Inc $ 2 - $ 0 -
Sagimet Biosciences inc $ 1 - $ 0 -
China Pharma Holdings Inc $ 1 $ 8 $ -3 -
Bespoke Extracts Inc $ 1 $ 0 $ -3 -
Kazia Therapeutics Limited $ 1 $ 15 $ -8 -
Bioadaptives Inc $ 1 $ 0 $ -1 -
9 Meters Biopharma Inc $ 1 - $ -46 27
International Stem Cell Corporation $ 1 $ 8 $ 0 -
Panbela Therapeutics Inc $ 1 - $ -20 -
Sangui Biotech International Inc $ 1 $ 0 $ 0 -
Nanomix Corp $ 1 - $ -12 -
Infinity Pharmaceuticals Inc $ 1 $ 3 $ -41 23
Oncosec Medical Incorporated $ 1 - $ -29 -
Oncorus Inc $ 1 - $ -91 -
Transcode Therapeutics Inc $ 1 - $ -19 -
Otonomy Inc $ 1 $ 0 $ -52 -
The Greater Cannabis Company Inc $ 1 - $ 0 -
Rebus Holdings Inc $ 0 - $ 1 -
Wellness Center Usa Inc $ 0 $ 0 $ -2 -
Skinvisible Inc $ 0 $ 0 $ -2 -
Lannett Company Inc $ 0 $ 289 $ -274 -
Calithera Biosciences Inc $ 0 $ 27 $ -21 -
Allarity Therapeutics Inc $ 0 $ 24 $ -20 -
Evofem Biosciences Inc $ 0 $ 15 $ 67 -
Third Harmonic Bio Inc $ 0 - $ 17 -
American Bio Medica Corporation $ 0 $ 1 $ 1 -
Clearmind Medicine Inc $ 0 - $ -7 1
Musclepharm Corporation $ 0 $ 50 $ -19 248
Altamira Therapeutics Ltd $ 0 $ 0 $ -27 -
Respirerx Pharmaceuticals Inc $ 0 - $ -3 -
Generex Biotechnology Corp $ 0 $ 4 $ -37 -
Sunwin Stevia International Inc. $ 0 $ 37 $ -4 421
Abeona Therapeutics Inc $ 0 $ 5 $ -36 -
Q Biomed inc $ 0 $ 0 $ -1 8
Fsd Pharma Inc $ 0 - $ -24 -
Acura Pharmaceuticals inc $ 0 $ 2 $ -1 -
Statera Biopharma Inc fka Cytocom Inc $ 0 $ 4 $ -103 -
Khosla Ventures Acquisition Co $ 0 - $ 6 -
Hillstream Biopharma Inc $ 0 - $ -9 -
Cardax Inc $ 0 $ 1 $ -5 -
Kaya Holdings Inc - $ 0 $ -6 17
Cen Biotech Inc - - $ 2 -
Cnbx Pharmaceuticals Inc - $ 0 $ -4 -
Cannapharmarx Inc - - $ -8 -
Earth Science Tech Inc - $ 0 $ 0 -
Galmed Pharmaceuticals Ltd - $ 2 $ 18 -
Angion Biomedica Corp - $ 30 $ -24 -
4d Pharma Plc - $ 1 $ -32 -
Protokinetix Incorporated - - $ -2 -
Propanc Biopharma Inc - - $ -3 -
Sunshine Biopharma Inc - $ 15 $ -25 -
Alterity Therapeutics Limited - - $ 0 -
Xenetic Biosciences Inc - $ 2 $ -4 -
Neuropathix Inc. - $ 0 $ -4 -
Avricore Health Inc - $ 1 $ -1 -
Medicure Inc - $ 18 $ 1 -
Phio Pharmaceuticals Corp - - $ -12 -
Grifols Sa - - $ 304 -
Stealth Biotherapeutics Corp - - $ -53 -
Intellipharmaceutics International Inc - $ 0 $ -3 -
Renovaro Biosciences Inc - - $ -40 -
Sonoma Pharmaceuticals Inc - $ 13 $ -6 -
Purple Biotech Ltd - - $ 22 -
Painreform Ltd - - $ -7 -
Silence Therapeutics Plc - $ 12 $ -39 -
Amryt Pharma Plc - $ 223 $ 0 1
Biodexa Pharmaceuticals Plc - $ 1 $ -8 -
Avenir Wellness Solutions Inc - $ 5 $ -26 -
Landec Corporation - $ 451 $ -64 -
Major Pharmaceutical Preparations Industry $ 3,745,831 $ 789,161 $ 75,263 1,237,282
  Recent News from Major Pharmaceutical Preparations Industry
Renovaro Biosciences Inc

Headline: Renovaro Biosciences Inc Continues to Report Zero Revenue, Reflecting Limited Growth in Q2 Fiscal Year 2023 Pharmaceutical preparations company experiences no change in revenue compared to previous year, raises concerns over lack of expansion prospects.

Renovaro Biosciences Inc, a major pharmaceutical preparations company, has released its financial report for the fiscal period ending June 30, 2023. During this period, the company experienced zero gain per share, an improvement compared to the same period a year ago when it reported a gain of $0.33 per share. It also represents an increase from the preceding financial reporting period when the company reported a loss of $0.08 per share.
In terms of revenue, Renovaro Biosciences Inc did not experience any change compared to the corresponding financial reporting period a year ago. The revenue remained at $0.00 million, and there was no sequential change either. This stability in revenue could be an area of concern for the company, as it suggests a lack of growth or expansion in its operations.
Immuron Limited

Immuron Limited reports decreased revenue and widened net loss in Q4 2023



In the financial fourth quarter of 2023, Immuron Limited, a major pharmaceutical preparations company, reported its financial results, which revealed a decrease in revenue and widened net loss. These figures mark a notable change compared to the corresponding financial reporting period from the previous year. This article aims to examine the context behind Immuron Limited's financial results, including its stock performance and implications for investors.
Financial Results:
Immuron Limited disclosed a revenue of $1.480365 million in the financial fourth quarter of 2023 after experiencing a net loss of $-3.787 million. These figures signify a departure from balanced books in the corresponding period a year earlier. Additionally, in the financial year 2023, the company announced a loss of $-3.79 million alongside a revenue of $1.48 million. In comparison to the prior financial year, the net loss per share has widened from $-1.25 to $-1.66, indicating a financial decline. However, it is important to note that the net loss remained unchanged from $0.00 million a year earlier.
Procyon Corporation

Observing the fourth quarter of 2023 numbers, Procyon Corporation reveals concerning revenue decline



Procyon Corporation recently released their financial results for the fourth quarter of the 2023 earnings season. While the company reported unaltered earnings per share (EPS), a decline in revenue and other key indicators raises concerns about the company's future performance. This article aims to interpret the financial results and discuss their potential impact on Procyon Corporation going forward.
1. Earnings per Share (EPS) and Revenue Performance:
Procyon Corporation maintained an EPS of $0.00 in the fourth quarter, suggesting stability in their profitability. However, the company experienced a modest revenue decline of -0.589% year-on-year, amounting to $1.20 million. This decline sets Procyon apart from the rest of the Major Pharmaceutical Preparations industry, which recorded a revenue improvement during the same period.
Innovation Pharmaceuticals Inc

Revitalizing Growth: Innovation Pharmaceuticals Inc's Revenue Stagnant, But Positive Signs Emerge

Innovation Pharmaceuticals Inc, a pharmaceutical company, recently announced its financial results for the fiscal year ending June 30, 2023. During this period, the company achieved a break-even point of $0.00 per share, which was the same as the previous year and the previous quarter.
However, the company did not generate any revenue during this quarter, remaining at $0.00 million, the same as the previous year and quarter. This indicates that there was no growth in the company's revenue during this period.
Additionally, Innovation Pharmaceuticals Inc reported a net shortfall of $-0.681 million for the fiscal year ending June 30, 2023. This is a significant improvement compared to the deficit of $-1.626 million reported in the same quarter a year ago. Although still in a shortfall, the company has managed to reduce its losses, which may indicate positive efforts in managing their expenses.
Palatin Technologies Inc

Palatin Technologies Inc Defies the Odds with Explosive Revenue Growth in Q4 2023, While Major Pharmaceutical Preparations Companies Struggle to Turn Profitable

Financial News Report:
Palatin Technologies Inc Reports Strong Revenue Growth in Q4 2023, Despite Stock Deficit
Palatin Technologies Inc (PTN) has announced a substantial revenue advancement of 109.038% year on year to $1.76 million in the fourth quarter of 2023. However, the company posted a deficit per stock at $-0.98. Despite the stock deficit, PTN's revenue experienced significant growth compared to its peers in the Major Pharmaceutical Preparations industry. Most corporations in this industry saw an average revenue advance of 3.04% during the same period.
In comparison to the preceding reporting period, PTN's revenue surged by 47.359% from $1.20 million and the deficit improved from $0.00 per share. This strong revenue growth indicates a positive trend for Palatin Technologies Inc.
Ibio Inc

Ibio Inc's Fourth Quarter Earnings Show Alarming Surge in Losses and Share Value Decline



In the aftermath of Ibio Inc's recently released fourth-quarter earnings report, the company appears to be grappling with mounting losses and a steep decline in its share value. The financial results for the quarter ended in 2023 revealed a concerning trend of escalating losses for the biotechnology firm.
Earnings Overview:
During the fourth quarter of the 2023 earnings season, Ibio Inc reported a significant increase in its loss per share compared to the same period in the prior year. The loss per share surged from $-0.10 a year ago to $-0.97, representing a substantial deterioration. Additionally, the company witnessed a sequential increase in losses, reaching $-0.55 per share from the previous financial reporting period.
Mei Pharma Inc

A Surprising Twist in the Fourth Quarter of 2023


Date: November 15, 2023
Mei Pharma Inc, a leading pharmaceutical company, has experienced a significant turnaround in their financial performance during the financial fourth quarter of 2023, with a reduction in losses per share and improved earnings per share. However, the company witnessed a sharp decline in revenue compared to the previous year, mainly attributed to slowing demand and other market factors.
During the financial fourth quarter of 2023, Mei Pharma Inc reduced their loss per share from $-0.13 a year ago to $-0.08 per share, indicating a 38.46% improvement. Furthermore, earnings per share showed a significant improvement from $-2.32 per share in the preceding quarter to the current figure. These positive numbers highlight the company's ability to manage their expenses effectively and generate better returns for their shareholders.
Dividend

XOMA's Commitment to Shareholders: Declares Dividends Amidst a Challenging Stock Performance

XOMA Corporation, a biotechnology company based in Emeryville, California, announced today that their Board of Directors has approved cash dividends for holders of XOMA's Series A and Series B Cumulative Preferred Stock. This news comes amidst a troubled period for XOMA's stock performance, with a decline of -3.75% over the past week and a YTD performance of -16.08%. However, there is a ray of hope as the stock is currently trading 14.5% above its 52-week low.
The declaration of quarterly preferred stock dividends by XOMA is a positive move for the company and its shareholders. Dividends are a way for companies to distribute profits to their stockholders, creating an additional incentive for investors to hold onto their shares. By authorizing these cash dividends, XOMA is demonstrating its commitment to rewarding its investors and maintaining a strong relationship with them.
Cannapharmarx Inc

Cannapharmarx Inc. Shows Promising Results with Reduced Losses and Growing Revenue in First Quarter of 2023



The first quarter of 2023 has shown significant promise for Cannapharmarx Inc, a major player in the pharmaceutical preparations industry. While the company has not revealed any top-line figures yet, industry observers are examining the operating shortfall of $-0.720277 million, shedding light on the positive performance of the firm during this period. By comparing it to previous quarters and assessing other growth indicators, we can anticipate a bullish outlook for Cannapharmarx Inc in the near future.
Reduced Losses and Growing Revenue:
In the first quarter of 2022, Cannapharmarx Inc experienced an operating shortfall of $-0.715558 million. However, with effective cost-cutting measures and revenue growth strategies, the company has managed to improve its financial performance in Q1 2023. The company's losses of $-2.072 million in the first quarter of 2022 have been reduced to $-1.413 million, showcasing a significant improvement in their bottom line. This reduction of losses is indicative of a more efficient and profitable operation.
Benitec Biopharma Inc

Benitec Biopharma Inc Revolutionizes the Biotech Industry with Remarkable Q2 2023 Financial Performance!

Financial News Report: Benitec Biopharma Inc Reports Loss in Fiscal Year 2023
Benitec Biopharma Inc, a major pharmaceutical preparations company, recently released its financial results for the fiscal interval ending June 30, 2023. The company reported a net loss of $-4.661 million, compared to a deficit of $-5.067 million in the corresponding reporting season a year ago.
In terms of earnings per share (EPS), Benitec Biopharma Inc experienced a decline from $-0.16 per share in the previous reporting season to $-0.17 per share in the current period. However, this is an improvement compared to the earnings of $-0.62 per share a year before the reporting season.






Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com